GLSI:NASDAQ, Greenwich LifeSciences, Inc.

Why GLSI stock rose on November 17

Greenwich LifeSciences, Inc. rose 35.9% on Tuesday, November 17, 2026, on 1,107,471 shares, 8.5 times its average daily volume. Headlines around the move:

GLSI stock overview

Greenwich LifeSciences, Inc. (GLSI:NASDAQ) closed at $18.70 on November 17, 2026, up 35.90% on the day. The stock trades 45.2% below its 52-week high of $34.10 and 140.4% above its 52-week low of $7.78. Over the past year, it gained 130.0%. Greenwich LifeSciences, Inc. is part of the Health Care sector.

Key figures

Price
$18.70
Day change
+35.90%
Volume
1,107,471
Average volume
130,240
Market cap
274M+
52-week range
$7.78 – $34.10
50-day average
$16.52
200-day average
$20.91

Price action over the past year

In 252 trading sessions since November 17, 2025, GLSI closed higher on 133 days (53%). Its best day was November 17, 2026 (+35.90%) and its worst was August 28, 2026 (-16.34%). The stock moved 10% or more in a single session 31 times. It opened at least 5% above the previous day's high 5 times.

Recent signals

GLSI news

About Greenwich LifeSciences, Inc.

Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.

Similar stocks

Find more stocks like GLSI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.